Establishment Labs to Present at J.P. Morgan Healthcare Conference

Each January, San Francisco becomes a temporary capital of healthcare capital, where companies translate their missions into the language of markets. On January 14, 2026, Establishment Labs — a medical device company devoted to breast aesthetics and reconstruction — will send its two most senior executives to the 44th Annual J.P. Morgan Healthcare Conference, a gathering where institutional attention can shape a company's trajectory for the year ahead. The presence of both CEO Peter Caldini and CFO Raj Denhoy signals that Establishment Labs arrives not merely to be seen, but to be understood —